Edap (EDAP +3.4%) gains after saying the FDA has given the thumbs-up on a pre-market approval application for its Ablatherm Integrated Imaging HIFU device, a high-intensity utrasound treatment for low-risk, localized prostate cancer. [View news story]
This is good news for our wallets as well as many men with this cancer!
Annaly Capital (NLY) is asking shareholders to allow management to form a new company with which to run the firm from. Similar to arrangements at competitors like American Capital and Invesco, the move means pay of individual executives would no longer be disclosed. Annaly's CEO made $35M in 2011, chump-change for hedge funds, but raising eyebrows for a financial firm post-crisis. [View news story]
Gee, just as I was about to load up on NLY, this pops up. I guess that $35 mil was not enough for this exec. What about the other leaders in this business? Can it be found out how much they make?
Bank of America Corp (BAC) declares $0.01/share quarterly dividend, in line with previous. Forward yield 0.35%. For shareholders of record Mar. 01. Payable Mar. 22. Ex-div date Feb. 27. (PR) [View news story]
A penny? A penny? Why don't they keep it in the till or invest it in Ford??
Edap (EDAP +3.4%) gains after saying the FDA has given the thumbs-up on a pre-market approval application for its Ablatherm Integrated Imaging HIFU device, a high-intensity utrasound treatment for low-risk, localized prostate cancer. [View news story]
Annaly Capital (NLY) is asking shareholders to allow management to form a new company with which to run the firm from. Similar to arrangements at competitors like American Capital and Invesco, the move means pay of individual executives would no longer be disclosed. Annaly's CEO made $35M in 2011, chump-change for hedge funds, but raising eyebrows for a financial firm post-crisis. [View news story]
Bank of America Corp (BAC) declares $0.01/share quarterly dividend, in line with previous. Forward yield 0.35%. For shareholders of record Mar. 01. Payable Mar. 22. Ex-div date Feb. 27. (PR) [View news story]